Dale A. Sander serves as Executive at Humacyte, Inc., where they oversee executive responsibilities. Since joining the company, Dale A. Sander has executed 6 insider transactions totaling $324.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 16, 2025 involved receiving (via award) 311,100 shares valued at $0.
Dale A. Sander currently holds 313,100 shares of Humacyte, Inc. (HUMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dale A. Sander has been a net seller of HUMA stock. They have purchased $61.1K and sold $263.1K worth of shares.
Dale A. Sander's most recent insider trade was on Nov 16, 2025, when they sold 311,100 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.56 |
| Discretionary |
| Aug 27, 2024 | HUMA | $263.1K | Sale | 39,389 | $6.68 | Discretionary |
| Dec 16, 2022 | HUMA | $52.0K | Purchase | 20,000 | $2.60 | Discretionary |
| Dec 13, 2022 | HUMA | $0 | Will Acquisition | 600 | $N/A | Discretionary |
| May 17, 2022 | HUMA | $9.1K | Purchase | 2,000 | $4.53 | Discretionary |